Date Filed | Type | Description |
02/16/2007 |
8-K
| Quarterly results |
02/16/2007 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
02/16/2007 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
02/15/2007 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
02/13/2007 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2007 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC |
02/07/2007 |
8-K
| Changes in Control of Registrant, Other Events, Financial Statements and Exhibits |
02/02/2007 |
SC 13G
| DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC |
02/01/2007 |
8-K
| Acquisition/merger/asset purchase announced |
01/03/2007 |
SC 13D/A
| Engelberg Charles reports a 4.5% stake in PRAECIS PHARMACEUTICALS, INC. |
12/21/2006 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta... |
11/20/2006 |
SC 13D/A
| Efficacy Capital, Ltd. reports a 2.9% stake in PRAECIS PHARMACEUTICALS, INC. |
11/16/2006 |
SC 13D/A
| Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC. |
11/16/2006 |
SC 13D
| Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC. |
11/09/2006 |
10-Q
| Quarterly Report for the period ended September 30, 2006 |
11/09/2006 |
8-K
| Quarterly results |
10/10/2006 |
SC 13D
| Efficacy Capital, Ltd. reports a 9.4% stake in PRAECIS PHARMACEUTICALS, INC. |
08/04/2006 |
10-Q
| Quarterly Report for the period ended June 30, 2006 |
08/04/2006 |
8-K
| Quarterly results |
06/20/2006 |
8-K
| Entry into a Material Definitive Agreement, Material Impairments, Regulation FD Disclosure, Financial Statements and Exhibits |
05/08/2006 |
8-K
| Other Events, Financial Statements and Exhibits |
05/05/2006 |
10-Q
| Quarterly Report for the period ended March 31, 2006 |
05/05/2006 |
8-K
| Quarterly results |
04/13/2006 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities |
04/10/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/23/2006 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/21/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/17/2006 |
10-K
| Annual Report for the period ended December 31, 2005 |
03/15/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/09/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/03/2006 |
SC 13G
| LOTSOFF CAPITAL MANAGEMENT reports a 4.7% stake in PRAECIS PHARMACEUTICALS INC |
02/22/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
02/14/2006 |
SC 13G/A
| ELM RIDGE CAPITAL MANAGEMENT LLC reports a 0% stake in Praecis Pharmaceuticals, Inc. |
02/10/2006 |
SC 13G/A
| CONUS PARTNERS INC reports a 1.9% stake in Praecis Pharmaceuticals Incorporated |
|